Amicus Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on Amicus Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Amicus Therapeutics Inc Strategy Report
- Understand Amicus Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Amicus Therapeutics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 14 Jul 2022 | Ultragenyx Pharma Acquires Marketing Rights of Mepsevii in Japan from Amicus Therapeutics | Asset Transaction |
Ultragenyx Pharmaceutical Inc
|
Amicus Therapeutics Inc |
| 29 Sep 2021 | Amicus Therapeutics Enters into Agreement with Caritas Therapeutics | Partnership | - |
Amicus Therapeutics Inc
Caritas Therapeutics Inc
|
| 29 Sep 2021 | Amicus Therapeutics to Raise up to USD200 Million in Private Placement | Equity Offering |
Invus LP
Avoro Capital Advisors LLC
Sphera Global Healthcare Master Fund
Perceptive Advisors LLC
Janus Henderson Investors
Redmile Group LLC
|
Amicus Therapeutics Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward